EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Advances in Hemophilia: New Treatments and Complications in Laboratory Testing/Monitoring

Sibgha Zaheer, Guy Young

Clinics in Laboratory Medicine · 2026-06 · 46 (2) · 167-183

DOI: 10.1016/j.cll.2026.02.002 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinics in Laboratory Medicine, 2026-06. Verfasst von Sibgha Zaheer und 1 weiteren Autor:innen. Beteiligte Einrichtung: University of Southern California, Keck School of Medicine, Los Angeles, CA, USA; Cancer and Blood Disorders Institute, Children's Hospital Los Angel…. Hauptthemen laut MEDLINE: Hemophilia A. Die Arbeit nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The landscape of hemophilia treatment has recently undergone a drastic transformation with the advent of novel therapies, including extended half-life factor concentrates, nonfactor therapies, rebalancing agents, and gene therapies. While these advancements have improved patient outcomes, they have introduced challenges in laboratory monitoring. Traditional assays such as prothrombin time, activated partial thromboplastin time, and 1-stage clotting assays may not accurately reflect the hemostatic status in patients receiving these new treatments. This article reviews the evolution of hemophilia therapies and the corresponding challenges in laboratory testing, emphasizing the need for updated monitoring strategies to ensure optimal patient management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemophilia AHumansBlood Coagulation TestsAntibodies, Monoclonal, HumanizedAntibodies, BispecificBlood Coagulation Factors

Stichwörter der Autor:innen

Chromogenic assayEmicizumabHemophiliaNonfactor therapiesOne-stage assayRebalancing agentsThrombin generation

Substanzen

Antibodies, Monoclonal, HumanizedemicizumabAntibodies, BispecificBlood Coagulation Factors

Autor:innen und Institutionen

  • University of Southern California, Keck School of Medicine, Los Angeles, CA, USA; Cancer and Blood Disorders Institute, Children's Hospital Los Angeles, Los Angeles, CA, USA. Electronic address: szaheer@chla.usc.edu.
  • University of Southern California, Keck School of Medicine, Los Angeles, CA, USA; Cancer and Blood Disorders Institute, Children's Hospital Los Angeles, Los Angeles, CA, USA.

Zitieren

APA

Zaheer, S., & Young, G. (2026). Advances in Hemophilia: New Treatments and Complications in Laboratory Testing/Monitoring. Clinics in Laboratory Medicine, 46(2), 167-183. https://doi.org/10.1016/j.cll.2026.02.002

Vancouver

Zaheer S, Young G. Advances in Hemophilia: New Treatments and Complications in Laboratory Testing/Monitoring. Clinics in Laboratory Medicine. 2026;46(2):167-183. doi:10.1016/j.cll.2026.02.002

BibTeX
@article{Zaheer2026,
  author = {Zaheer, Sibgha and Young, Guy},
  title = {Advances in Hemophilia: New Treatments and Complications in Laboratory Testing/Monitoring},
  journal = {Clinics in Laboratory Medicine},
  year = {2026},
  volume = {46},
  number = {2},
  pages = {167--183},
  doi = {10.1016/j.cll.2026.02.002}
}
Kostenlos starten →